Estimate prognosis in COPD
This formula is taken from Celli et al (2004), based on the evaluation of 207 patients with COPD and the subsequent prospective validation on a similar cohort of 625 patients. Patients were recruited in the United States, Venezuela, and Spain and all were judged to have stable COPD.
61% of deaths were secondary to respiratory insufficiency. Multiple variables were assessed and each was evaluated as a possible independent predictor of mortality. FEV1, body-mass index, 6-minute walk distance, and the modified MRC dyspnea scale were found to be the best predictors of death among these variables. The BODE Index predicts all-cause mortality and respiratory-related mortality with better accuracy than the FEV1 alone.
The hazard ratio for all-cause mortality is 1.34 for every one-point increase in the BODE score. The hazard ratio for respiratory-related mortality is 1.62 for every one-point increase in the BODE score.
Celli BR et al.
Celli BR et al.
This formula is taken from Celli et al (2004), based on the evaluation of 207 patients with COPD and the subsequent prospective validation on a similar cohort of 625 patients. Patients were recruited in the United States, Venezuela, and Spain and all were judged to have stable COPD.
61% of deaths were secondary to respiratory insufficiency. Multiple variables were assessed and each was evaluated as a possible independent predictor of mortality. FEV1, body-mass index, 6-minute walk distance, and the modified MRC dyspnea scale were found to be the best predictors of death among these variables. The BODE Index predicts all-cause mortality and respiratory-related mortality with better accuracy than the FEV1 alone.
The hazard ratio for all-cause mortality is 1.34 for every one-point increase in the BODE score. The hazard ratio for respiratory-related mortality is 1.62 for every one-point increase in the BODE score.
Celli BR et al.
Celli BR et al.
© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.